Skip to main content

Sol-Gel Technologies Ltd.

SLGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001684693

In the last 90 days, Sol-Gel Technologies Ltd. insiders filed 7 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $98.1M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Sol-Gel Technologies Ltd. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of SLGL: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders20217−1
Shares5.39M120.1K5.23M−43.8K (−0.8%)
Value$3.67M$81.6K$4.86M+$1.28M (+35.6%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held Sol-Gel Technologies Ltd. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to SLGL in Q4 2024
InstitutionSharesValue% of portfolio
Raymond James Financial Inc108,990$101.4K0.00%
Virtu Financial LLC13,343$12.0K0.00%
Simplex Trading, LLC27$00.00%

Sold out (4)

Institutions that held Sol-Gel Technologies Ltd. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of SLGL in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Prosperity Wealth Management, Inc.163,400$111.1K
Citadel Advisors LLC39,629$26.9K
Two Sigma Securities, LLC25,887$17.6K
XTX Topco Ltd10,922$7.43K

Not filed for Q4 2024 yet (2)

Institutions that held Sol-Gel Technologies Ltd. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SLGL in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Raymond James Financial Services Advisors, Inc.88,461$60.1K
Raymond James & Associates31,623$21.5K